Chemical proteomics-driven discovery of oleocanthal as an Hsp90 inhibitor.
Hsp90, a key target in cancer therapy, has been identified as the main partner of oleocanthal, an olive oil bioactive compound. A combination of chemical and biological assays disclosed its mechanism of action at the molecular level.